COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Advances in glaucoma research continue

November 18, 2003

Article

Paul Lichter, MD, for the Collaborative Initial Glaucoma Treatment Studyreported the results of an analysis of variables reflecting iOP controlassociated with visual field loss over 5 years. Four hundred twenty-sevenpatients who were followed for more than 6 years were analyzed. They hadbeen randomly assigned to medical therapy or a filtering procedure. Dr.Lichter reported that visual field loss was significantly associated witha larger maximum IOP, increased IOP variation, and a higher mean IOP. Dr.Lichter suggested that ophthalmologists focus on keep patient IOPs under18 mm Hg for as long as possible and avoid wide swings in IOP.